← Open Payments lookup

CATHERINE CUNNINGHAM: Open Payments

NPI 1982009486 · LAKEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$434 in 24 payments from 12 companies in 2025. Trend: 2023 $687 · 2024 $296 · 2025 $434

Food & beverage: $434
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.7$120
Janssen Pharmaceuticals, Inc2$41
Otsuka America Pharmaceutical, Inc.2$39
Neurocrine BioSciences, Inc.2$36
Supernus Pharmaceuticals, Inc.2$36
Teva Pharmaceuticals USA, Inc.2$35
Alkermes, Inc.2$32
Lilly USA, LLC1$22
Takeda Pharmaceuticals U.S.A., Inc.1$21
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19

Products named: COBENFY, SPRAVATO, REXULTI, INGREZZA, Qelbree, AMYVID, TRINTELLIX, CAPLYTA.

Industry payments across NJ — which companies pay providers there.